← Back
Exozymes
EXOZ · listed on Nasdaq · worth $44.99 million
$4.52
+9.44% on Nov 2
Five insider buys in the last year, $6.4K in all. None in the last two weeks.
Green dot = an insider bought red = sold◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
7.2M shares
77% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, one insider bought Exozymes stock and one insider sold. None of the 1 sale is marked on its filing as planned in advance; all by company executives.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
Chief Executive Officer
Michael Heltzen
Bought $1.9K on Aug 26 — 250 shares at $7.60, 1.7% of what they now own.
1 of 1 earlier purchase did better than the S&P 500
All reports
Every insider trade and SEC report we hold for Exozymes.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
2 more with Pro →